Penggunaan Sitostatika Pada Pasien Kanker Dewasa Di Ruang Kemoterapi RSUP Fatmawati Periode Bulan Januari Sampai Juni Tahun 2020
##plugins.themes.academic_pro.article.sidebar##
##plugins.themes.academic_pro.article.main##
Abstract
Chemotherapy is one of the treatment modalities for systemic cancer which is often chosen, especially to treat advanced, local and metastatic cancers. The administration of cytostatics is carried out in a special room to avoid exposure to cytostatics and for the safety of patients and officers giving cytostatics. The administration of cytostatics is adjusted to the diagnosis of cancer. Therefore, the researcher wanted to know how the use of cytostatics in cancer patients in the Chemotherapy room of Fatmawati Hospital, especially in adult patients.
This study aims to determine the characteristics of adult cancer patients who undergo chemotherapy in the chemotherapy room, and the use of cytostatics based on drug class and type, and how the characteristics of adult patients relate to the use of cytostatics.
The research method was carried out by taking data from adult patients diagnosed with cancer and administering chemotherapy from January to June 2020 in the chemotherapy room by paying attention to inclusion and exclusion criteria.
The results showed 1272 adult patients who administered chemotherapy and 3785 cytostatic preparations from January to June 2020. From the evaluation, it was found that the most cancer patient characteristics based on gender were 78.22% women with an age range of ≥40 - 60 years of 60.14 % and the most disease diagnoses were breast cancer at 50.63%. The use of cytostatics based on group is antimetabolite with pyrimidine analogues (Fuorouracil (5-FU) and Gemcitabine) and folic acid analogues (Methotrexate) with a value of 28.22%. The highest use of cytostatic types was Fluorouracil (5-FU), which was 19.47%. The relationship between patient characteristics and use of cytostatics is in gender, age and indication of drug use (disease diagnosis).
The results of this study are very useful considering the scarcity of literature due to the limited implementation units that carry out the provision of sitostatics such as Fatmawati General Hospital. Therefore, it can be suggested for further research related to the relationship between drug use and cancer diagnosis in the context of drug availability and cost analysis, as well as evaluation of the side effects that occur when administering cytostatics through documented interviews with patients.
Keyword : Chemotherapy, Sitostatics, Cancer, Fatmawati General Hospital.
##plugins.themes.academic_pro.article.details##
References
2. KEMENKES. Buletin Kanker. Pusat Data dan Informasi Kementrian Kesehatan RI 2015. 2015.
3. Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., … Aggarwal, B. B. (2008). Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharmaceutical Research, 25(9), h. 2097-2116.doi: 10.1007/s11095-008-9661-9.
4. Rasjidi.2009. Deteksi Dini & Pencegahan Kanker Pada Wanita. Jakarata: Sagung Seto.
5. Arima,Aria,C, 2006. Paralisis Saraf Kranial Multipel pada Karsinoma Nasofaring.Available from: http://library.usu.ac.id/download/fk/D0400193.pdf [Accessed 17 May 2010].
6. International Union Against Cancer (UICC). 2009. Jika Tidak Dikendalikan 26 Juta Orang Di Dunia Menderita Kanker. Diperoleh dari: http://www.depkes.go.id/index.php/berita/press-release/1060-jika-tidakdikendalikan-26-juta-orang-di-dunia-menderita-kanker-.html.
7. Adiwijono.(2006). Teknik-teknik pemberian kemoterapi, dalam Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M.K., & Setiati, S. (2006).Buku ajar ilmu penyakit dalam.(3rd Ed.). (hlm 1900-1902). Jakarta: Pusat Penerbit Departemen Penyakit Dalam FKUI.
8. Yusuf, dkk (2006) An In Vitro Inhibition of Human Malignant Cell Growth of Crude Water Extract of Cassava (Manihot esculenta Crantz) and Comercial Linamarin. Songklanakarin J. Sci. Tehnol 28(1):145-155.
9. American Cancer Society. 2011. Global Cancer Statistics. CA: A Cancer Journal for Clinicians Volume 61 Number 2 March/April 2011
10. Departemen Kesehatan RI. 2009. Undang-Undang Republik Indonesia Nomor 44 Tahun 2009 tentang Rumah Sakit. Jakarta: Depkes RI.
11. Siregar,C.J.P., 2004, Farmasi Rumah Sakit, Penerbit Buku Kedokteran ECG, Jakarta, 20, 37-42.
12. Junaidi, Iskandar. (2007). Kanker. Jakarta: PT. Bhuana Ilmu Populer Keperawatan edisi 2. Jakarta: Salemba Medika Keperawatan: Pedoman Skripsi, Tesis dan Instrumen Penelitian
13. Mangan, Y., 2009, Cara Sehat Mencegah dan Mengatasi Kanker, Agromedia Pustaka, Jakarta.
14. Tjay, Tan Hoan dan Kirana Rahardja, 2007, Obat-Obat Penting Khasiat, Penggunaan dan Efek-Efek Sampingnya, Edisi Keenam, 262, 269-271, PT. Elex Media Komputindo, Jakarta.
15. Dipiro, J.T., et al. 2005. Pharmacotherapy Handbook. Sixth edition.The Mc. Graw Hill Company. USA. Page : 1891-1939.
16. Guyton A. C., Hall J. E. 1997. Buku Ajar Fisiologi Kedokteran.Edisi 9.Jakarta : EGC. P. 208 – 212, 219 – 223, 277 – 282, 285 – 287.
17. Guyton A. C. And Hall J.E. 2008.Buku Ajar Fisiologi Kedokteran.Edisi 11.Jakarta : Penerbit Buku Kedokteran EGC. h. 693 – 700,912 – 917.
18. Gilman, A.G., 2007, Goodman & Gilman Dasar Farmakologi Terapi, diterjemahkan oleh Tim Alih Bahasa Sekolah Farmasi ITB, Edisi X, 877, Penerbit Buku Kedokteran, EGC, Jakarta.
19. Grunberg, SM., 2004, Chemotherapy-Induced Nausea and Vomitting : Prevention, Detection and Treatment-How are We Doing ?, The Journal of Supportive Oncology, 2 : 1-12.
20. Jeffery, H., Richard, D., and James-Chatgilaou, G., 1998, Clinical Pharmacy : A pratical Approach, The Society of Hospital of Australia, Pharmacists of Australia, page 360
21. Husni, H.S. 2010. Evaluasi Pengendalian Sistem Informasi Penjualan. Jakarta Wirawan. (2012 ). Evaluasi Teori, Model, Standar, Aplikasi dan Profesi. Jakarta: Rajawali Pers.
22. Beni Ahmad Saebani, 2008, Metode Penelitian, Bandung: Pustaka Setia
23. Brown, T.R. 2006, Handbook of Institutional Pharmacy Practice, 4th edition, American Society of Health-System Pharmacy, Maryland, USA.
24. Dahlan, Ahmad. 2014. Populasi dan Sampel Penelitian.
25. http://www.eurekapendidikan.com/2014/10/Populasi-dan-sampelpenelitian/.
26. Desen,W.(2008). Buku Ajar Onkologi Klinis, edisi 2. Jakarta : Balai Penerbit FKUI.
27. De Jong, W,. R. Sjamsuhidajat. 2005. Buku Ajar Ilmu Bedah Edisi 2. EGC. Jakarta. Departemen Kesehatan Republik Indonesia,2006. Profil Kesehatan 2008. Jakarta. Kozier.(2010). Buku Ajar Praktik Keperawatan Klinis.Edisi 5.Jakarta : EGC
28. Menkes RI. (2014). Peraturan Menteri Kesehatan Nomor 58 Tahun 2014 Tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Jakarta: Departemen Kesehatan RI.
29. Notoatmodjo, S. 2012. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
30. 2004. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
31. Sugiyanto. 2013. Model-Model Pembelajaran Inovatif. Surakarta: Yuma Pustaka.
32. Nursalam. 2014. Metodologi penelitian ilmu keperawatan. Jakarta: Salemba Medika
33. Price, A. Sylvia, Lorraine Mc. Carty Wilson, 2006, Patofisiologi : Konsep Klinis Proses-proses Penyakit, Edisi 6, (terjemahan), Peter Anugrah, EGC, Jakarta.
34. Sugiyono. 2013. Statistik Untuk Penelitian. Bandung : Alfabeta, cv.
35. Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg. Med. Chem. Lett. 2018 Sep 15;28(17):2816-2826. [PubMed]
36. Nurgat ZA, Smythe M, Al-Jedai A, Ewing S, Rasheed W, Belgaumi A, Ahmed SO, Ashour M, Al Agil A, Siddiqui K, Aljurf M. Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation. J Oncol Pharm Pract. 2015 Oct;21(5):339-47.
37. Metrix,http://www.kalbemed.com/searchpage/ArtMID/556/ArticleID/413/METRIX Metamizole, https://www.drugbank.ca/drugs/DB04817 Epirubicin, https://www.drugbank.ca/drugs/DB00445 Bendamusti, https://www.drugbank.ca/drugs/DB06769